TSE:NVC - Neovasc Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseC$1.74Today's RangeC$1.76 - C$1.8252-Week RangeC$0.49 - C$6.07Volume46,869 shsAverage Volume111,876 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium. Receive NVC News and Ratings via Email Sign-up to receive the latest news and ratings for NVC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolTSE:NVC Previous Symbol CUSIPN/A Webwww.neovasc.com Phone+1-604-2704344Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapC$0.00 OptionableNot Optionable Neovasc (TSE:NVC) Frequently Asked Questions What is Neovasc's stock symbol? Neovasc trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NVC." How were Neovasc's earnings last quarter? Neovasc Inc. (TSE:NVC) issued its earnings results on Wednesday, November, 14th. The company reported ($0.80) earnings per share (EPS) for the quarter. The firm had revenue of $0.63 million for the quarter, compared to analyst estimates of $0.60 million. View Neovasc's Earnings History. When is Neovasc's next earnings date? Neovasc is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Neovasc. Has Neovasc been receiving favorable news coverage? News stories about NVC stock have trended neutral this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Neovasc earned a news impact score of 0.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the near future. Who are Neovasc's key executives? Neovasc's management team includes the folowing people: Paul L. Geyer, Independent Chairman of the BoardFred Colen, President, Chief Executive OfficerChristopher Clark, Chief Financial Officer, Corporate SecretaryBrian McPherson, Chief Operating OfficerVicki Lee Bebeau, Vice President - Clinical AffairsRandy Lane, Vice President - Research & DevelopmentAlexei J. Marko, DirectorJane H. Hsiao Ph.D., Independent Director (Age 69)Douglas Glen Janzen, Independent DirectorWilliam O'Neill, Independent Director (Age 61) How do I buy shares of Neovasc? Shares of NVC and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Neovasc's official website? The official website for Neovasc is http://www.neovasc.com/. How can I contact Neovasc? Neovasc's mailing address is 13562 Maycrest Way Suite 5138, RICHMOND, BC V6V 2J7, Canada. The company can be reached via phone at +1-604-2704344. MarketBeat Community Rating for Neovasc (TSE NVC)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 65 (Vote Outperform)Underperform Votes: 43 (Vote Underperform)Total Votes: 108MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/18/2019 by MarketBeat.com StaffFeatured Article: What is the yield curve?